<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60399">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01912235</url>
  </required_header>
  <id_info>
    <org_study_id>02/02/2010</org_study_id>
    <nct_id>NCT01912235</nct_id>
  </id_info>
  <brief_title>Arginine Synthesis in Healthy Adult Humans</brief_title>
  <official_title>Arginine Synthesis in Healthy Adult Humans: Does Proline or Glutamate Provide the 5-Carbon Chain?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <authority>Canada: Research Ethics Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arginine synthesis in mammals is a complex process involving at least 8 enzymes and
      intracellular and interorgan transfer of substrates.

      The investigators have shown in our neonatal studies that there is no conversion of
      glutamate to arginine but proline label appears in ornithine, citrulline and arginine. It is
      clear therefore that arginine is synthesized in human neonates from proline.

      In adults the source of the carbon backbone is less clear.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Through a series of test in healthy adults using tandem mass spectrometry with carbon
      labeled GLN and nitrogen labeled PRO to determine the dietary source for the carbon chain of
      ORN, CIT and ARG. Additionally, using Nitrogen labeled GLN, we will identify the source of
      the nitrogen atoms in these amino acids.

      Using guanidino - 15N2 arginine, 1-13C Glutamine, 2-15N Glutamine and 15N Proline we will be
      able to:

        1. determine the flux of arginine and proline in healthy adult volunteers

        2. determine and compare the flux of carbon and nitrogen labeled glutamine

        3. demonstrate whether glutamine or proline provides the carbon backbone for ornithine,
           citrulline and arginine in adults.

        4. the source of the N atoms in ornithine, citrulline and arginine.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Blood Isotope Levels</measure>
    <time_frame>8 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Test Study 1:  2-15N glutamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To determine the contributions make by glutamine to the provision of nitrogen for ornithine, citrulline and arginine syntesis in adults.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Study 2: 15N2 arginine &amp;15N proline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>administration of 15N2 arginine &amp;15N proline to measure arginine and proline flux</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study Test 3: 1-13C glutamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>to determine to contribution of glutamine to the carbon skeleton of ornithine, citrulline and arginine in adults.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2-15N glutamine</intervention_name>
    <description>Glutamine with N15 isotope tracer</description>
    <arm_group_label>Test Study 1:  2-15N glutamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>15N2 arginine and 15N proline</intervention_name>
    <description>Arginine and Proline isotope tracers</description>
    <arm_group_label>Test Study 2: 15N2 arginine &amp;15N proline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1-13C glutamine</intervention_name>
    <description>Glutamine carbon isotope tracer</description>
    <arm_group_label>Study Test 3: 1-13C glutamine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  5 men of average weight 80 kg will be studied

          -  healthy, with no know disease of liver, and/or kidney

          -  weight stable

        Exclusion Criteria:

          -  weith loss or gain over the last three months

          -  on medications known to affect amino acid metabolism

          -  known liver, kidney disease condition
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Pencharz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 7, 2013</lastchanged_date>
  <firstreceived_date>July 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Dr. Paul Pencharz</investigator_full_name>
    <investigator_title>Emeritus Scientist</investigator_title>
  </responsible_party>
  <keyword>Arginine synthesis</keyword>
  <keyword>15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
